Enzyme Inhibitors as Drugs: Medical Applications and Scope

Enzyme inhibitors target the specific enzymes at cell, tissue and organ level as drugs. The enzyme inhibitors inhibit specific enzymes and act as chemo-sensitive, anti-inflammatory, antiangiogenic and antibiotic drug action. Enzyme inhibitors in drug targeting serve the purpose in treatment of several molecular diseases. The present review simulates the concept of enzyme inhibition to define enzyme deficiency disease with cause of enzyme deficiency due to missing genes. It explores further the new enzyme inhibitors including chemo-sensitive, nutraceuticals, herbiceuticals, phytochemicals used in drug targeting. Review inspires with new mechanisms of enzyme inhibitor targeting action for potential disorders such as carbohydrate storage and lipid storage diseases, lysosomal disorders, cancer, asthma and chronic obstructive pulmonary disease (COPD), cardiovascular diseases, erectile dysfunction, gastrointestinal disorders, hepatitis B virus infection, hepatitis C virus infection, herpes virus infections, human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), rheumatoid arthritis and related inflammatory diseases. In conclusion, now concept of reverse pharmacology is emerging in the direction of traditional natural nutraceutical-herbiceutical-phytochemical remedies in targeting enzymes to develop applications in theranosis means defining new diseases and therapeutic monitoring.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-07-04
DOI
https://doi.org/10.5281/zenodo.15804005
Primary Topic
Pharmacology and Nanomedicine Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enzyme Inhibitors as Drugs: Medical Applications and Scope

Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Nanomedicine Research
article

Enzyme Inhibitors as Drugs: Medical Applications and Scope

article en

Abstract

Enzyme inhibitors target the specific enzymes at cell, tissue and organ level as drugs. The enzyme inhibitors inhibit specific enzymes and act as chemo-sensitive, anti-inflammatory, antiangiogenic and antibiotic drug action. Enzyme inhibitors in drug targeting serve the purpose in treatment of several molecular diseases. The present review simulates the concept of enzyme inhibition to define enzyme deficiency disease with cause of enzyme deficiency due to missing genes. It explores further the new enzyme inhibitors including chemo-sensitive, nutraceuticals, herbiceuticals, phytochemicals used in drug targeting. Review inspires with new mechanisms of enzyme inhibitor targeting action for potential disorders such as carbohydrate storage and lipid storage diseases, lysosomal disorders, cancer, asthma and chronic obstructive pulmonary disease (COPD), cardiovascular diseases, erectile dysfunction, gastrointestinal disorders, hepatitis B virus infection, hepatitis C virus infection, herpes virus infections, human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), rheumatoid arthritis and related inflammatory diseases. In conclusion, now concept of reverse pharmacology is emerging in the direction of traditional natural nutraceutical-herbiceutical-phytochemical remedies in targeting enzymes to develop applications in theranosis means defining new diseases and therapeutic monitoring.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 71%
Pharmacology and Nanomedicine Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.